|
David F. Hardwick's MD, FRCPC, FCAP career focused on the field of paediatric pathology. Hardwick was involved with The University of British Columbia (UBC) for more than sixty years as both a student and professor, and is a Professor Emeritus. His research included the first description of histopathologic implications of differential survival of Wilms' Tumors to pathogenesis of L-methionine toxicity and administrative/management research.〔http://www.cahs-acss.ca/david-f-hardwick-2/〕 ==The University of British Columbia== In 2001, UBC awarded Hardwick an Honorary Doctor of Laws degree in recognition of his commitment to the principles of academic freedom. In his acceptance speech〔http://www.library.ubc.ca/archives/speeches/hardwick.html〕 he spoke of ''" ...the opportunity to chase one's own rainbow's end..."'', noting that such opportunity does not exist widely outside the university environment, and exhorting new graduates to do what they can to preserve academic freedom. Hardwick attributed his achievements to his ability to build connections with multiple institutional entities, and to strengthen connections among different generations of medical practitioners. He spoke publicly of the importance of collegial activity in an article "Our Academy as an Exciting Academic Forum":〔THE ACADEMY—The Newsletter of the United States and Canadian Academy of Pathology Volume l No. 2 Fall 2000〕 As Associate Dean, Research and Planning, in the (UBC Faculty of Medicine ) from 1990 to 1996, Hardwick helped build government relationships that advanced the academic and scientific missions of UBC and its teaching hospitals. In addition, Hardwick also improved relationships between UBC and its teaching hospitals and for establishing teaching and research facilities at these sites. Among those achievements are: * 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「David F. Hardwick」の詳細全文を読む スポンサード リンク
|